Rheumatoid factors determined by fluorescence immunoassay: comparison with qualitative and quantitative methods.

Fluorescence immunoassay (FIA), a relatively new technique for measuring rheumatoid factors (RF), is automated, quantitative, and calibrated against the Centers for Disease Control reference material for RF. We studied the FIA method in relation to a panel of RF methods, both qualitative [latex (LA) and sheep cell agglutination (SSCA)], and quantitative [nephelometry and enzyme-linked immunoassay (ELISA)]. Regression analysis revealed a highly significant correlation between FIA and either LA (r = 0.90) or nephelometry (r = 0.87). The correlation between FIA and either SSCA (r = 0.62) or ELISA (r = 0.67) was less strong. FIA had the highest sensitivity (91%) of all these methods; the specificity was 86%. FIA provides an accurate, sensitive, and specific measure of RF, and is a good alternative for laboratories wanting to replace titer methods with automated laboratory analysis.

Adult rheumatoid arthritis is associated with MC1, a new HLA-D encoded determinant.

We evaluated the association of a new HLA-D encoded determinant, MC1, with adult rheumatoid arthritis (RA). This determinant associates with DR1 and DR4 and can be defined by serological typing. We found MC1 in 83% of 80 patients with RA vs 43% of controls. Although the frequencies of DR1 and DR4 were both significantly increased in patients with RA compared with controls, MC1 had the highest relative risk (6.2) of any HLA-DR antigen tested. MC1 negative and positive populations were not significantly different in any of a variety of clinical and laboratory variables including age, sex, disease duration, age at onset, hours of morning stiffness, functional class, joint count, presence of subcutaneous nodules or bony erosions, frequency of side effects to gold or D-penicillamine, sedimentation rate, and antinuclear antibody.